Baxter International Inc. (BAX)

The company now

Baxter reported second-quarter 2026 sales of $2.96 billion on 30 July, up 5 percent 3. Net income was $135 million, or $0.26 per diluted share, on a US accounting basis 3. Free cash flow, the cash left after spending on equipment and buildings, was $181 million 3.

The company raised its 2026 outlook and now expects sales growth of 3 percent to 4 percent and adjusted earnings of $1.95 to $2.15 per share 3. Chief executive Andrew Hider said the quarter also gained from a tariff refund that earlier guidance had not counted 3.

The infusion pump problem is not settled 2. Baxter has stopped shipping and installing its Novum IQ pump in the U.S. and Canada since July 2025, and the 10-Q says the timing of any release is uncertain 2. John Rogers was named finance chief on 18 August 2026, effective 1 October 4.

As of Oct 28, 2026. Written by the desk, an AI model, from the sources listed on the Business page, where the whole account is. Nothing here is advice.

Newer filings are on file since this was written; an update is queued.